JEFFREY W. NAVEN

• Head of Corporate Financial Planning and Analysis. Leader of global planning team responsible for $500M revenue and >$1B Operating expense budget across >20 countries. Lead Budget and Long Range Plan process, due diligence on potential partnerships and deals, and implementation of efficiency projects.
• Interim head of Europe, Middle East, Africa (EMEA) Commercial Operations for one year. Led a team of 25 commercial and medical professionals across ten countries, generating sales >$20M. Key leader on due diligence, in-licensing, and initial launch preparation for partnered asset currently generating over $30M in sales. Drove negotiations and execution of four distributor partnership deals.
• Finance head for EMEA and interim finance head for Latin America. Partnered closely with Commercial, Medical, and Regional/Country GMs in development of budgets, P&Ls, and scenario analyses, growing the region from scratch to > $25M in revenue, $20M in expenses, and 30 full time headcount. Developed expansion plans and led cross-functional teams in implementation of key processes such as payroll, benefits, treasury, and accounting, ensuring the company met mandatory financial/tax/legal/audit reporting requirements in each country.
• Integration leader of acquisition of Dimension Therapeutics. Ensured operations continued smoothly pre and post close, thereby enabling key IND filing timelines were met.

• Provided financial planning and decision analysis to a variety of companies, including Long Range Planning, product P&L analysis, international expansion, make/buy analysis, and Board of Director presentations.

Regional Finance Lead, EEMEA

• Led Financial Planning & Analysis organization responsible for Emerging Europe, Middle East, Turkey, Russia, and Africa, headquartered in Istanbul, Turkey. Managed financial planning and reporting for a $500M business and $150M expense budget in 27 countries. Let a finance team of 8 across four countries.

Acquisition Integration Leader

• Integration leader of $700M acquisition of Mustafa Nevzat (MN) Pharmaceuticals, an Istanbul, Turkey based company. Developed and executed integration plan of Amgen policies, procedures, and systems as leader of 8 cross-functional team members across four countries. Ensured integration goals met while ensuring key employees retained and operational and financial goals were met during the integration.

Financial Planning & Analysis Executive Director, 2001-2012

• Held increasing levels of responsibility in Financial Planning and Analysis in support of Corporate, R&D, Operations, and Manufacturing, and Internal Audit. Managed diverse teams across several countries with operating budgets >$1B. Led numerous process improvement, partnership and acquisition due diligence and integrations.

• Held leadership positions in commercial, manufacturing, and product line management with full P&L/cost accountability
• Led OEM and aftermarket sales initiatives that generated $20M in incremental revenue and development of business proposals valued in excess of $300M
• Led 25 engineers and technicians as manufacturing plant manager, delivering a developmental product to the US Navy that generated $16M in incentive fees due to early delivery

• Amassed over 2500 hours and 500 aircraft carrier landings in the F-14 Tomcat fighter
• Held increasing roles of responsibility in aircraft maintenance, aircrew training, combat mission planning, safety, and operational advisor to development programs
• Flew 50 combat missions
• Graduate, Navy Fighter Weapons School (TOPGUN)